Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.3050
-0.0050 (-1.61%)
Aug 18, 2026, 3:58 PM EST
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $326.91 million as of August 19, 2026. Its market cap has decreased by -43.73% in one year.
Market Cap
326.91M
Enterprise Value
293.54M
Revenue
141.01M
Ranking
n/a
PE Ratio
6.24
Stock Price
$0.31
ChartMarket Cap Chart
Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 326.91M, an increase of 3,314.13%. That is a compound annual growth rate of 13.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 326.91M | -37.94% |
| Dec 31, 2025 | 526.74M | -8.88% |
| Dec 31, 2024 | 578.04M | 306.60% |
| Dec 29, 2023 | 142.16M | 374.74% |
| Dec 30, 2022 | 29.95M | -10.40% |
| Dec 31, 2021 | 33.42M | -36.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 441.70M |
| Growth Stalk Holdings | 39.17M |
| Radnostix | 35.72M |
| High Sierra Technologies | 28.98M |
| Raphael Pharmaceutical | 28.25M |
| MariMed | 27.39M |
| Earth Science Tech | 25.88M |
| Healthy Extracts | 19.90M |